Wrinkles are the result of a complex set of biological mechanisms related to skin aging. Over time, fibroblasts—which are cells responsible for producing collagen, elastin, and glycosaminoglycans—slow down their activity. The skin then loses density, firmness, and elasticity. Added to this are the oxidation of the dermal structural proteins, collagen glycation, and reduced sebum production, all of which impair cellular cohesion and the skin’s ability to regenerate. External factors add to these intrinsic processes, such as exposure to sunlight, which accounts for nearly 80% of visible skin aging in light phototypes, but also to tobacco smoke and to air pollution, which accelerate wrinkle formation due to the oxidative stress and chronic inflammation they cause.
Many treatments today are capable of reducing wrinkles, but none can completely eliminate them.
Injections of hyaluronic acid, for example, restore volume and firmness to the skin and help compensate for the loss of dermal support proteins. However, these effects are temporary and require regular touch-ups. Similarly, biomimetic peptides, such as argireline, have shown promising results in reducing wrinkle depth and improving skin texture. Their action is based on direct communication with skin cells: they mimic neurotransmitters to limit muscle contractions. These mechanisms provide a visible improvement, but not a complete elimination of wrinkles.
For example, a clinical study evaluated the efficacy of Argireline on periorbital wrinkles in 60 participants. They were randomly assigned to apply a 10% Argireline emulsion or a placebo twice daily for four weeks. As shown in the photo below, the participants’ wrinkles were reduced but did not disappear.